Bioniche Animal Health discovers, develops, manufactures and markets animal health products worldwide.
Headquartered in Canada, the Company was formed in 1979 to develop vaccines and other pharmaceutical-based products for the preventative health management of animal diseases. Bioniche Animal Health is now a division of Bioniche Life Sciences Inc., a public company (TSX: BNC and ASX: BNC).
Bioniche Animal Health markets a broad portfolio of products for companion animals, horses and the livestock industry, with a focus on four key areas:
02 December 2013
New FDA-approved generic drug, NexHA™, now available to treat joint dysfunction in horses
Belleville, Ontario, December 2nd, 2013 – A new product will now provide U.S. veterinarians with an alternative to treat... [read more]
15 July 2013
Bioniche's Lead Animal Health Product Gains Access to Seven Additional European Markets
BELLEVILLE, ON, July 15, 2013 /CNW/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical... [read more]
13 May 2013
Bioniche Engages Evercore Partners to Assist in the Divestment of its Animal Health Business
BELLEVILLE, ON, May 13, 2013 /CNW/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian... [read more]view all recent news